ÂÜÀòÂÒÂ×

Tom has spent over 45 years in the biotech and pharmaceutical industry with leading roles from early drug discovery to big pharma and biotech across several therapeutic areas. An internationally recognized speaker on drug discovery and biotech start-up companies, Tom has worked as a C-Level executive, company secretary, and VP/director of various therapeutic projects and portfolio management organizations. His extensive experience includes venture capital, investment, strategic business development plans, and due diligence for in-and out-licensing drugs for biotech and pharma. A President Emeritus and Honorary Fellow of the British Pharmacological Society, he holds a Ph.D., DSc from Manchester University and is a Fellow of the Royal Society of Biology (FRSB).